云南白药10月29日公告,第三季度营收为94.6亿元,同比增长0.86%;归母净利润为11.38亿元,同比下降12.16%。前三季度营收为299.15亿元,同比增长0.76%;归母净利润为43.27亿元,同比增长4.93%。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.